Mathematical modelling of core regulatory mechanism in p53 protein that activates apoptotic switch.


Journal

Journal of theoretical biology
ISSN: 1095-8541
Titre abrégé: J Theor Biol
Pays: England
ID NLM: 0376342

Informations de publication

Date de publication:
07 02 2019
Historique:
received: 28 03 2018
revised: 29 10 2018
accepted: 10 11 2018
pubmed: 16 11 2018
medline: 24 3 2020
entrez: 16 11 2018
Statut: ppublish

Résumé

The p53 protein, a tumour suppressor, is a key player in the DNA damage response. The activation of apoptosis by p53 involves the intrinsic apoptotic pathway to eliminate stressed cells that contain DNA lesions. Recent experiments have found that apoptosis happen in an all-or-none switch like manner  (Albeck et al., 2008; Rehm et al., 2002). We focus on modelling the mechanism of p53 activation of apoptosis in response to sustained high DNA double-strand breaks. The aim of the research is to investigate the design principles behind the regulation of p53 activation of apoptotic switch. Building on previous models (Chong et al., 2015; Zhang et al., 2009a), we developed a mathematical model that incorporated the molecular interactions in the core regulation of p53 and the apoptosis initiation module involving Puma, Bcl2 and Bax. Activation of Bax was assumed to be an indicator of apoptosis initiation. Chen et al. (2013) suggested that one of the components in the p53 pathway may control a threshold activation of apoptosis. We hypothesized that ATM auto-activation is the component that controls p53 threshold activation of apoptosis with ATM's multi-site autophosphorylation depending on damage intensity. The constructed model demonstrated how molecular interactions and stress signalling molecule ATM's auto-activation of the p53 network dictate cell fate decisions. Our simulation results are qualitatively consistent with the experimental findings of all-or-none activation of apoptosis and predicted overexpression of Bcl2 as a factor in causing malfunction of the apoptotic switch. We present a simplified yet plausible model of molecular mechanism that controls p53 activation of apoptotic switch.

Identifiants

pubmed: 30439375
pii: S0022-5193(18)30555-1
doi: 10.1016/j.jtbi.2018.11.008
pii:
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
BBC3 protein, human 0
BCL2 protein, human 0
Proto-Oncogene Proteins 0
Proto-Oncogene Proteins c-bcl-2 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0
bcl-2-Associated X Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-147

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Ket Hing Chong (KH)

Biomedical Informatics Lab, School of Computer Science and Engineering, Nanyang Technological University, 639798, Singapore.

Sandhya Samarasinghe (S)

Complex Systems, Big Data and Informatics Initiative (CSBII) and Centre for Advanced Computational Solutions (C-fACS), Lincoln University, Christchurh, New Zealand.

Don Kulasiri (D)

Department of Molecular Biosciences, and Centre for Advanced Computational Solutions (C-fACS), Lincoln University, Christchurh, New Zealand. Electronic address: don.kulasiri@lincoln.ac.nz.

Jie Zheng (J)

School of Information Science and Technology, ShanghaiTech University, Pudong District, Shanghai 201210, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH